Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium Czechia Germany Italy
  • Study on the Effects of ZN-c3 for Patients with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Recruiting

    1 1 1
    Belgium France Italy Poland Spain
  • Study of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Recruiting

    1 1 1 1
    Czechia Finland France Germany Greece Italy +3
  • Study on Bevacizumab Dose Equivalence for Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer Using Bevacizumab, Olaparib, Carboplatin, and Paclitaxel

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Poland
  • Study on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer

    Not recruiting

    1 1 1
    Belgium France Germany Ireland Italy The Netherlands +1
  • Study of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Italy
  • Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Czechia Denmark Germany Greece Ireland +5
  • Study on Carboplatin, Paclitaxel, Bevacizumab, and Rucaparib for Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Patients

    Not recruiting

    1 1 1
    Italy
  • Study on the Effectiveness of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin and Sodium Thiosulfate for Ovarian Cancer Patients Undergoing Surgery

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France
  • Study Comparing Paclitaxel, Carboplatin, and Oregovomab with Paclitaxel, Carboplatin, and Placebo for Patients with Advanced Ovarian Cancer

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Hungary Italy Spain